The Executive Committee on Global Health and Human Security is a unique public-private platform that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field.
In 2023, Japan will host the G7 Summit in Hiroshima, the “City of Peace.” Ahead of the Summit, JCIE has established the Hiroshima G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture.
With just 10 more years until the Sustainable Development Goals’ (SDG) target year of 2030, there is a pressing need for Japan to increase the development impact of its global health assistance and make global health funding more strategic. This commission aims to reassess how to utilize Japan’s ODA in a more strategic manner to advance global health, adapt to structural shifts in the development field, and increase the efficacy and impact of its funding.
In 2018, JCIE’s Executive Committee on Global Health and Human Security created a Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia. The group, comprised of 15 experts from industry, academia, and government, seeks to formulate recommendations on how Japan could improve access to pharmaceuticals and medical devices in Asia.
Briefing on the ACT-Accelerator at the Special Session of the Executive Committee on Global Health and Human Security
On May 19th, ten leaders of the global health organizations that comprise the Access to COVID-19 Tools (ACT) Accelerator, as well as Ambassador Carl Bildt, WHO Special Envoy for ACT-Accelerator, joined the Special Session of the Executive Committee to explain how this unprecedented global health partnership is helping develop and equitably distribute critical COVID-19 tools.
Global Health Working Group Lancet Article | Protecting Human Security: Proposals for the G7 Ise-Shima Summit in Japan
This article shares policy recommendations to develop: global structures that enable effective preparedness for health emergencies, knowledge-sharing platforms for health system resilience and sustainability, and research, development, and system innovations for global health security.
JCIE Report | Advancing a Global Health Agenda in the SDG Era: Enhancing Japan’s Leadership Role in 2019–2020
This report details the insights from an ad hoc, 15-member “JCIE International Advisory Group on Global Health (IAG)” on the topic of supporting countries in implementing universal health coverage and advancing health and welfare of societies.
JCIE Publication | A COVID-19 Emergency Response Strategy—Establishing Domestic Vaccine Development Capacity During a Public Health Emergency
This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19 emergency response.
This report was submitted to the Japanese and Italian governments in January 2009 for consideration for the 2009 G8 Summit agenda.